Nicole Shani Gunasekera, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Panniculitis, Lupus Erythematosus | 1 | 2017 | 8 | 0.670 |
Why?
|
| Focal Dermal Hypoplasia | 1 | 2016 | 9 | 0.640 |
Why?
|
| Thiosulfates | 1 | 2017 | 62 | 0.640 |
Why?
|
| Vitiligo | 2 | 2014 | 92 | 0.630 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 432 | 0.560 |
Why?
|
| Ultraviolet Therapy | 1 | 2014 | 81 | 0.520 |
Why?
|
| Bone Diseases | 1 | 2016 | 427 | 0.460 |
Why?
|
| Calcinosis | 1 | 2017 | 1456 | 0.350 |
Why?
|
| Skin | 3 | 2017 | 4355 | 0.320 |
Why?
|
| Medicaid | 1 | 2019 | 2635 | 0.300 |
Why?
|
| Cellulitis | 2 | 2019 | 234 | 0.280 |
Why?
|
| Silicone Gels | 1 | 2021 | 40 | 0.210 |
Why?
|
| Dermatology | 2 | 2021 | 866 | 0.210 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2021 | 50 | 0.210 |
Why?
|
| Buttocks | 1 | 2021 | 117 | 0.210 |
Why?
|
| Medical Tourism | 1 | 2021 | 54 | 0.200 |
Why?
|
| Injections, Intralesional | 1 | 2017 | 282 | 0.150 |
Why?
|
| Nails | 1 | 2016 | 285 | 0.130 |
Why?
|
| Diagnostic Errors | 2 | 2019 | 1274 | 0.130 |
Why?
|
| Hair | 1 | 2016 | 445 | 0.120 |
Why?
|
| Cost Savings | 1 | 2019 | 923 | 0.120 |
Why?
|
| Erythema | 1 | 2014 | 264 | 0.120 |
Why?
|
| Skin Diseases | 1 | 2021 | 1090 | 0.110 |
Why?
|
| Antioxidants | 1 | 2017 | 1681 | 0.090 |
Why?
|
| Malnutrition | 1 | 2015 | 631 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2019 | 2752 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 2043 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2015 | 1552 | 0.080 |
Why?
|
| Medicare | 2 | 2021 | 5787 | 0.080 |
Why?
|
| Telemedicine | 1 | 2021 | 2624 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 16017 | 0.070 |
Why?
|
| Critical Illness | 1 | 2015 | 2543 | 0.060 |
Why?
|
| Child | 3 | 2021 | 74387 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3448 | 0.060 |
Why?
|
| Dominican Republic | 1 | 2021 | 70 | 0.050 |
Why?
|
| Betamethasone | 1 | 2021 | 48 | 0.050 |
Why?
|
| Melanoma | 1 | 2018 | 5260 | 0.050 |
Why?
|
| Humans | 13 | 2021 | 717237 | 0.050 |
Why?
|
| Electronics | 1 | 2021 | 293 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5335 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 23409 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7497 | 0.050 |
Why?
|
| Skin Diseases, Infectious | 1 | 2019 | 75 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2021 | 41221 | 0.040 |
Why?
|
| Female | 9 | 2021 | 377909 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 410 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2019 | 515 | 0.040 |
Why?
|
| Adult | 5 | 2021 | 212451 | 0.040 |
Why?
|
| Male | 8 | 2021 | 351380 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 15271 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2017 | 251 | 0.040 |
Why?
|
| Infant | 1 | 2016 | 34574 | 0.030 |
Why?
|
| Tachycardia | 1 | 2017 | 609 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1370 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2021 | 3963 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 62348 | 0.030 |
Why?
|
| Skin Pigmentation | 1 | 2014 | 282 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2019 | 983 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 13274 | 0.030 |
Why?
|
| Middle Aged | 5 | 2018 | 215041 | 0.030 |
Why?
|
| Leg | 1 | 2017 | 1139 | 0.030 |
Why?
|
| Photography | 1 | 2014 | 531 | 0.030 |
Why?
|
| Emergencies | 1 | 2017 | 1126 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6542 | 0.020 |
Why?
|
| Bacteremia | 1 | 2017 | 973 | 0.020 |
Why?
|
| Aged | 5 | 2021 | 162856 | 0.020 |
Why?
|
| United States | 3 | 2021 | 67798 | 0.020 |
Why?
|
| Biopsy | 1 | 2021 | 6753 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1744 | 0.020 |
Why?
|
| Age Factors | 2 | 2017 | 18798 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 85139 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2021 | 3473 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6280 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2791 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3566 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7074 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8066 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14903 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9407 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10660 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10451 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 72614 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20434 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16404 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 41095 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2014 | 21805 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19538 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 39887 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 58528 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 70864 | 0.010 |
Why?
|